alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(logo)Rialto 

         CAPITAL

 

 

**2017 AnnualStatement of Servicer Compliance (Item 1123)**

 

 

Poolingand Servicing Agreement (the “Pooling and Servicing Agreement”) dated as ofAugust 1, 2015 by and among Credit Suisse First Boston Mortgage SecuritiesCorp. as Depositor, Midland Loan Services, a Division of PNC Bank, NationalAssociation as Master Servicer, Rialto Capital Advisors, LLC as SpecialServicer, Pentalpha Surveillance LLC as Operating Advisor, Wells Fargo Bank,National Association as Certificate Administrator and Wells Fargo Bank,National Association as Trustee relating to the Credit Suisse First BostonMortgage Securities Corp., CSAIL 2015-C3 Commercial Mortgage Trust, CommercialMortgage Pass-Through Certificates Series 2015-C3 **(CSAIL 2015-C3)**

 

 

Theundersigned, a duly authorized officer of Rialto Capital Advisors, LLC, asspecial servicer (the “Special Servicer”), except for the Charles River PlazaNorth Whole Loan, herein certifies to the following:

 

1. Allservicing activities and performance of such servicing activities under thePooling and Servicing Agreement are performed on behalf of the SpecialServicer.

 

2. Areview of the servicing activities and performance by the Special Servicer forthe period of January 1, 2017 to December 31, 2017 (the “Reporting Period”) inaccordance with the Pooling and Servicing Agreement has been conducted under mysupervision.

 

3. Tothe best of my knowledge, based on such review, the Special Servicer hasfulfilled all of its obligations under the terms of the Pooling and ServicingAgreement, in all material respects for the Reporting Period and if there hasbeen a failure to fulfill any such obligations in any material respect, eachfailure and the nature and status thereof has been specifically identifiedherein.

 

 

Certifiedby: /s/ AdamSinger                                              Date: March 1, 2018

       AdamSinger, Managing Director
<TABLE> <S> <C>


<ARTICLE>                     5
                       
<MULTIPLIER>                  1
<CURRENCY>                    U. S. Dollars               
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               SEP-30-1998         
<PERIOD-START>                  OCT-01-1997   
<PERIOD-END>                    JUN-30-1998   
<EXCHANGE-RATE>                            1   
<CASH>                               156,917  
<SECURITIES>                               0         
<RECEIVABLES>                         10,350  
<ALLOWANCES>                               0  
<INVENTORY>                                0  
<CURRENT-ASSETS>                     167,267  
<PP&E>                               404,914  
<DEPRECIATION>                      (122,049)  
<TOTAL-ASSETS>                       450,132 
<CURRENT-LIABILITIES>                 23,782  
<BONDS>                                    0  
<PREFERRED-MANDATORY>                      0  
<PREFERRED>                                0  
<COMMON>                             122,146  
<OTHER-SE>                                 0         
<TOTAL-LIABILITY-AND-EQUITY>         450,132  
<SALES>                                    0  
<TOTAL-REVENUES>                       3,000  
<CGS>                                      0  
<TOTAL-COSTS>                          6,846  
<OTHER-EXPENSES>                           0  
<LOSS-PROVISION>                           0  
<INTEREST-EXPENSE>                     2,073  
<INCOME-PRETAX>                       (3,846)  
<INCOME-TAX>                               0 
<INCOME-CONTINUING>                   (3,846)  
<DISCONTINUED>                           (60) 
<EXTRAORDINARY>                            0 
<CHANGES>                                  0  
<NET-INCOME>                          (3,906)  
<EPS-PRIMARY>                              0        
<EPS-DILUTED>                              0  
        


</TABLE>
###### Editorial Note on Part 330

#### Editorial Note:

Nomenclature changes to part 330 appear at 69 FR 13717, Mar. 24, 2004.

#### § 330.3 Imprinting of solid oral dosage form drug products.

A requirement to imprint an identification code on solid oral dosage form drug products is set forth under part 206 of this chapter.

[58 FR 47959, Sept. 13, 1993]
§ 582.5308 Ferrous gluconate. ( a ) *Product.* Ferrous gluconate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.3900 Nasal dilator. ( a ) *Identification.* A nasal dilator is a device intended to provide temporary relief from transient causes of breathing difficulties resulting from structural abnormalities and/or transient causes of nasal congestion associated with reduced nasal airflow. The device decreases airway resistance and increases nasal airflow. The external nasal dilator is constructed from one or more layers of material upon which a spring material is attached, with a skin adhesive applied to adhere to the skin of the nose; it acts with a pulling action to open the nares. The internal nasal dilator is constructed from metal or plastic and is placed inside the nostrils; it acts by pushing the nostrils open or by gently pressing on the columella.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 874.9.
[64 FR 10949, Mar. 8, 1999]
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS INCURRED IN THE COMPANY'S
QUARTERLY REPORT ON FORM 10-QSB FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1998
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                       4,819,633
<SECURITIES>                                         0
<RECEIVABLES>                                    6,320
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,166,956
<PP&E>                                       1,479,319
<DEPRECIATION>                                 581,309
<TOTAL-ASSETS>                               6,168,450
<CURRENT-LIABILITIES>                        5,310,817
<BONDS>                                        179,374
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        220
<COMMON>                                        10,106
<OTHER-SE>                                   2,936,033
<TOTAL-LIABILITY-AND-EQUITY>                 6,168,450
<SALES>                                         22,025
<TOTAL-REVENUES>                                22,025
<CGS>                                          331,603
<TOTAL-COSTS>                                  331,603
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             243,601
<INCOME-PRETAX>                            (8,194,957)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,194,957)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,194,957)
<EPS-PRIMARY>                                    (.84)
<EPS-DILUTED>                                    (.84)
        

</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF MARCH 31, 1999 AND FROM THE STATEMENT OF OPERATIONS FOR THE THREE
MONTHS ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO 
SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-END>                                   MAR-31-1999
<CASH>                                         448,436
<SECURITIES>                                   0
<RECEIVABLES>                                  13,495
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0<F1>
<PP&E>                                         9,942,861
<DEPRECIATION>                                 0<F2>
<TOTAL-ASSETS>                                 10,555,569
<CURRENT-LIABILITIES>                          0<F1>
<BONDS>                                        5,030,224
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     5,331,193
<TOTAL-LIABILITY-AND-EQUITY>                   10,555,569
<SALES>                                        465,661
<TOTAL-REVENUES>                               468,566
<CGS>                                          0
<TOTAL-COSTS>                                  375,007
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             95,495
<INCOME-PRETAX>                                (1,936)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,936)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,936)
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1>THE PARTNERSHIP HAS AN UNCLASSIFIED BALANCE SHEET, THEREFORE THE BALANCE IS 
$0.
<F2>THIS INFORMATION IS NOT DISCLOSED IN THE PARTNERSHIP'S FORM 10-Q FILING.
</FN>
        

</TABLE>
<TABLE> <S> <C>


<PAGE>

<ARTICLE> 5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND IS QUALIFIED IN
ITS ENTIRETY BY REFERANCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   OTHER
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                           1,848
<SECURITIES>                                         0
<RECEIVABLES>                                   25,216
<ALLOWANCES>                                       867
<INVENTORY>                                     17,258
<CURRENT-ASSETS>                                54,315
<PP&E>                                          54,524
<DEPRECIATION>                                   8,852
<TOTAL-ASSETS>                                 102,808
<CURRENT-LIABILITIES>                           47,007
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           138
<OTHER-SE>                                      15,446
<TOTAL-LIABILITY-AND-EQUITY>                   102,808
<SALES>                                        227,269
<TOTAL-REVENUES>                               227,269
<CGS>                                          175,851
<TOTAL-COSTS>                                   70,826
<OTHER-EXPENSES>                                 2,379
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  2,742
<INCOME-TAX>                                   (24,529)
<INCOME-CONTINUING>                             (3,448)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (21,081)
<EPS-PRIMARY>                                    (1.53)
<EPS-DILUTED>                                    (1.53)




</TABLE>
<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         918,497
<SECURITIES>                                53,455,358
<RECEIVABLES>                                3,638,167
<ALLOWANCES>                                         0
<INVENTORY>                                  7,318,753
<CURRENT-ASSETS>                            70,462,692
<PP&E>                                       2,248,173
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              73,995,779
<CURRENT-LIABILITIES>                        6,434,568
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       192,946
<OTHER-SE>                                  67,368,265
<TOTAL-LIABILITY-AND-EQUITY>                73,995,779
<SALES>                                     20,119,048
<TOTAL-REVENUES>                            20,119,048
<CGS>                                        8,317,636
<TOTAL-COSTS>                               19,239,624
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (5,841,134)
<INCOME-TAX>                                (2,350,000)
<INCOME-CONTINUING>                         (3,491,134)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (3,491,134)
<EPS-BASIC>                                      (0.22)
<EPS-DILUTED>                                    (0.22)



</TABLE>
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

OFFICE OF POLLUTION PREVENTION AND TOXICS 

REGULATION OF NEW CHEMICAL SUBSTANCE 

PENDING DEVELOPMENT OF INFORMATION 

In the matter of: 

Konarka Technologies, Inc. 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

Premanufacture Notice Number: 

P-09-416 

Consent Order Modification 
CONSENT ORDER MODIFICATION 

FOR P-09- 416 

Page 6, paragraph (d)(2), of the Consent Order for P09-416, effective on November 1,2010 

(','original Order"), is hereby moditled as indicated in the attached page. All other tenns and 

conditions of the original Order remain unchanged. The modified Consent Order will not become 

effective until a signed copy is received by EP A, EPA will confIrm receipt by telephone, 

Datr 7 

Director 

Chemical Control Division 

Office of Pollution Prevention and Toxics 

Name: David Waller 

Title: Director of Materials and Chemistry 

Company: Konarka Technologies, Inc. 
MODIFIED CONSENT ORDER REQUIREMENTS 

FOR P09- 0416 

Page 6, paragraph (d)(2), of the original order is modified as follows: 

(2) Physical/chemical properties, lEthe Company 0"\11S or controls any site in the 

United States where the PMN substance is processed or used, the Company must 

submit the following materia! characterization data within 6 months (except for the 

water solubility test that must be submitted by July 5, 2011, and a waiver for 

conducting the dustiness test) after the expiration of the PMN review period: 

Water solubility (OECD 105 test method); 

Surface chemistry: EELS (electron energy loss spectroscopy) and/or XPS (ESCA) 

(X-ray photoelectron spectroscopy/electron spectroscopy for chemical analysis), 

functionalized probe AFM (atomic force microscopy), or Auger electron 

spectroscopy; and 

Particle size distribution that includes both individual PMN substance and their 

agglomerates as used in the workplace at sites controlled by the Company where 

the PMN substance are processed or used: TEM (transmission electron 

microscope), SEM (scanning electron microscope) using a dry particle counting 

method, and no counting after dispersion in a solution and evaporating solvent 

Description of the physical-chemical properties of the material tested should take into 

consideration the characterizations identified in the Guidance Mannal for the Testing of 

Manufactured Nanomaterials: OECD's Sponsorship Programme,
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.3300 Air-conduction hearing aid. ( a ) *Identification.* An air-conduction hearing aid is a wearable sound-amplifying device intended to compensate for impaired hearing that conducts sound to the ear through the air. An air-conduction hearing aid is subject to the requirements in § 800.30 or § 801.422 of this chapter, as applicable. The air-conduction hearing aid generic type excludes the group hearing aid or group auditory trainer, master hearing aid, and the tinnitus masker, regulated under §§ 874.3320, 874.3330, and 874.3400, respectively.
( b ) *Classification.* Class I (general controls). This device is exempt from premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 874.9.
[87 FR 50762, Aug. 17, 2022]
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.2    
  


 
 

Schedule
  
    Change of Control Employment Agreements    
  


        The following executive officers of the Company executed a Change of Control Employment Agreement substantially identical to the form of Change of Control
Employment Agreement incorporated herein by reference to Exhibit 10.2 to the Company's Annual Report on Form 10-K for the year ended December 31, 1997, except that the
number set forth in clause (a) of subparagraphs B. and C. in Section 6(a)(i) is as set forth below: 



	Officer
	 	Date of Agreement
	 	Section 6(a)(i)B and C

	

Ellen Richey	
 	

August 29, 1997	
 	

Three
	

Susan Gleason	
 	

February 13, 2002	
 	

One
	

Warren Wilcox	
 	

February 13, 2002	
 	

One
	

Anthony Vuoto	
 	

May 8, 2002	
 	

Three
	

Chaomei Chen	
 	

August 26, 2002	
 	

One












QuickLinks



Exhibit 10.2


Schedule Change of Control Employment Agreements
I 

I fl’! 34 

) 

/ Atton 

I 

! 

RTTTOFSEY EENmPINIONS 5124k32116 

I 

;nccal Opinion O-749 

at issued
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.275 Dried algae meal. ( a ) *Identity.* The color additive dried algae meal is a dried mixture of algae cells (genus *Spongiococcum,* separated from its culture broth), molasses, cornsteep liquor, and a maximum of 0.3 percent ethoxyquin. The algae cells are produced by suitable fermentation, under controlled conditions, from a pure culture of the genus *Spongiococcum.*
( b ) *Uses and restrictions.* The color additive dried algae meal may be safely used in chicken feed in accordance with the following prescribed conditions: ( 1 ) The color additive is used to enhance the yellow color of chicken skin and eggs.
( 2 ) The quantity of the color additive incorporated in the feed is such that the finished feed: ( i ) Is supplemented sufficiently with xanthophyll and associated carotenoids so as to accomplish the intended effect described in paragraph (b)(1) of this section; and
( ii ) Meets the tolerance limitation for ethoxyquin in animal feed prescribed in § 573.380 of this chapter.
( c ) *Labeling.* The label of the color additives and any premixes prepared therefrom shall bear in addition to the information required by § 70.25 of this chapter. ( 1 ) A statement of the concentrations of xanthophyll and ethoxyquin contained therein.
( 2 ) Adequate directions to provide a final product complying with the limitations prescribed in paragraph (b) of this section.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health and therefore batches thereof are exempt from the certification requirements of section 721(c) of the act.
Tel-Instrument Electronics Corp Appoints BDO Seidman as Its Auditors

Carlstadt, NJ-December 13, 2002-Tel-Instrument Electronics Corp, announced that
it has appointed BDO Seidman LLP as its independent auditors effective
immediately.

The Company previously filed a report on Form 8-K, which report stated that the
decision was not the result of any disagreement between the Company and its
previous auditors on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure. The prior auditors filed a
letter stating that it agreed with the foregoing statement.

The change in independent auditors was recommended by the Company's Audit
Committee and approved by its board of directors.

Tel-Instrument is a leading designer and manufacturer of avionics test and
measurement solutions for the global commercial air transport, general aviation,
and government/military aerospace and defense markets. Tel-Instrument provides
instruments to test, measure, calibrate and repair a wide range of airborne
navigation and communication equipment. For further information please visit our
website at www.telinstrument.com.

The Company's stock is traded in the NASDAQ System under the symbol TINE.

Contact: Mr. Joseph P. Macaluso
         201-933-1600